TheStreet Network:
TheStreet
|
MainStreet
|
BankingMyWay
|
RealMoney
Home
About Stockpickr
|
How to Use
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
» Most-Viewed
» Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
» More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
4 Tech Stocks to Trade (or Not)
3 Big Stocks to Trade (or Not)
5 Stocks Setting Up to Break Out
5 Dividend Stocks That Want to Pay You More
5 Stocks Under $10 Set to Soar
» More Articles
My Stockpickr
Log In
|
Join for Free
Stock Game
Health Care: Drugs
StemCells Inc. (STEM: NASDAQ)
$1.93
0.06 | 3.21%
05/17/13 - 04:00 PM ET
Quote
Ratings
Earnings
Fundamentals
Options Chain
Advanced Chart
Balance Sheet
Cash Flow
Income Statement
Growth Rates
Major Holders
Ratio Comparison
Portfolios with
STEM
Portfolio Name
User Type
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Breakout Stocks Of The Week...
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Setting Up...
User
8 Stocks Under $10 Making B...
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Moving Hig...
User
Stocks
Contributor
5 Biggest Drug-Stock Losers...
View All
Latest
STEM
Headlines from TheStreet
StemCells, Inc. Adds Byers Eye Institute At Stanford As Second Site For Phase I/II Clinical Trial In Dry Age-Related Macular Degeneration
04.18.13 | 09:04 am
StemCells, Inc. To Participate At 2013 Regen Med Investor Day In New York
04.15.13 | 09:04 am
StemCells, Inc. Enters Agreement To Receive $19.3 Million From California Institute For Regenerative Medicine To Help Fund IND For Alzheimer's Disease
04.11.13 | 09:04 am
CORRECTION -- StemCells, Inc. Closes $10 Million Debt Financing
04.09.13 | 04:04 pm
StemCells, Inc. Closes $10 Million Debt Financing
04.09.13 | 09:04 am
StemCells, Inc. Expands Patent Portfolio
03.20.13 | 09:03 am
StemCells, Inc. Reports Fourth Quarter And Full Year 2012 Financial Results And Provides Business Update
03.19.13 | 09:03 am
4 Biotech Stocks Under $5 to Watch
03.15.13 | 07:03 am
Stocks Mixed; Dow Reclaims 14,000
02.12.13 | 02:02 pm
StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial - Gains In Sensory Function Persist 12 Months After Stem Cell Transplant
02.12.13 | 07:02 am
More Financial News for STEM
Press Releases for
STEM
Over $400 Million Raised By U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings In 2012, Reports Brinson Patrick
- PR Newswire 04.08.13 | 08:04 am
See All Press Releases
Partner Headlines for
STEM
Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
- Seeking Alpha 03.28.13 | 09:03 am
StemCells Partners With R Biomedical
- Benzinga 10.30.12 | 09:10 am
Neuralstem Swinging For The ALS Fences
- Seeking Alpha 10.29.12 | 09:10 am
5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
- Seeking Alpha 10.09.12 | 09:10 am
StemCells Says Achieved First Neural Stem Cell Transplant Into Patient With Sensory Function Below the Level of Injury
- Benzinga 09.27.12 | 09:09 am
Why the bear market is finally ending
- NASDAQ 09.13.12 | 01:09 pm
Today's Market News To Trade On: 5 Stocks Moving On News
- Seeking Alpha 08.31.12 | 08:08 am
Nexen ENTERS Into Agreement With CNOOC and 4 Hot Stocks On the Move
- Wall St. Cheat Sheet 07.23.12 | 04:07 am
One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers
- Seeking Alpha 07.21.12 | 06:07 am
Healthcare Stock Insights: Vivus Wins FDA Diet Drug THUMBS UP, StemCells Give BACK
- Wall St. Cheat Sheet 07.19.12 | 08:07 am
Refresh Stock Quote for StemCells Inc. - STEM
Brown: Risk Weighti...
TV Networks Put Spo...
Icahn and Singer Ru...
Home
About Stockpickr
How to Use
Join for FREE
STOCK GAME
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
Most-Viewed
Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
4 Tech Stocks to Trade (or Not)
3 Big Stocks to Trade (or Not)
5 Stocks Setting Up to Break Out
5 Dividend Stocks That Want to Pay You More
5 Stocks Under $10 Set to Soar
More Articles
My Stockpickr
My Stockpickr Profile
Inbox
Add New Portfolio
Edit My Profile